Search research articles
Contact Us
Filters
Showing results (21-30 of 230) with videos related to
Page
of 23
Sort By:
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?
Stefan N Constantinescu, William Vainchenker
American Journal of Hematology
|
August 28, 2023
Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
Violaine Havelange, Stefan N Constantinescu
Blood
|
July 28, 2022
The 2 faces of ERK2 in MPNs
Violaine Havelange, Stefan N Constantinescu
Leukemia
|
January 17, 2008
Introduction to 'A special spotlight review series on BCR-ABL-negative myeloproliferative neoplasms'
A Tefferi, S N Constantinescu
The Journal of Biological Chemistry
|
January 29, 2005
Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors
Virginie Moucadel, Stefan N Constantinescu
Leukemia
|
January 26, 2017
Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile Janus kinase inhibition
E Leroy, S N Constantinescu
Frontiers in Endocrinology
|
April 10, 2023
Editorial: Recent advances in molecular and structural endocrinology
Pierre De Meyts, Stefan N Constantinescu
Revista De Chirurgie, Oncologie, Radiologie, O.R.L., Oftalmologie, Stomatologie. Oto-Rino-Laringologia
|
January 1, 1981
[Surgically treated vascular and paravascular diseases of the neck and face]
T Ghiţescu, M Mühle, N Constantinescu
Biochemical and Biophysical Research Communications
|
July 31, 1991
Topological regulation of cell-membrane phosphoinositidase C
S N Constantinescu, L M Popescu
Frontiers in Endocrinology
|
June 1, 2012
Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels
Roxana I Albu, Stefan N Constantinescu
Page
of 23
Search research articles
Search
Showing results (21-30 of 230) with videos related to
Sort By:
Page
of 23
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?
Stefan N Constantinescu, William Vainchenker
American Journal of Hematology
|
August 28, 2023
Molecular pathogenesis of myeloproliferative neoplasms: Where do we stand in 2023?
Violaine Havelange, Stefan N Constantinescu
Blood
|
July 28, 2022
The 2 faces of ERK2 in MPNs
Violaine Havelange, Stefan N Constantinescu
Leukemia
|
January 17, 2008
Introduction to 'A special spotlight review series on BCR-ABL-negative myeloproliferative neoplasms'
A Tefferi, S N Constantinescu
The Journal of Biological Chemistry
|
January 29, 2005
Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors
Virginie Moucadel, Stefan N Constantinescu
Leukemia
|
January 26, 2017
Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile Janus kinase inhibition
E Leroy, S N Constantinescu
Frontiers in Endocrinology
|
April 10, 2023
Editorial: Recent advances in molecular and structural endocrinology
Pierre De Meyts, Stefan N Constantinescu
Revista De Chirurgie, Oncologie, Radiologie, O.R.L., Oftalmologie, Stomatologie. Oto-Rino-Laringologia
|
January 1, 1981
[Surgically treated vascular and paravascular diseases of the neck and face]
T Ghiţescu, M Mühle, N Constantinescu
Biochemical and Biophysical Research Communications
|
July 31, 1991
Topological regulation of cell-membrane phosphoinositidase C
S N Constantinescu, L M Popescu
Frontiers in Endocrinology
|
June 1, 2012
Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels
Roxana I Albu, Stefan N Constantinescu
Page
of 23